GLUTAVOL

GLUTAVOL

GLUTAVOL the best glutamine matrix ever made!

GLUTAVOL
Vota este post

GLUTAVOL

GLUTAVOL has been developed under the highest technology to create
a natural anabolic environment supporting muscle cells in the form
of fuel and the metabolism of proteins. GLUTAVOL will enhance muscle
glycogen stores when combined with carbohydrates, which will prevent
muscle catabolism. GLUTAVOL will be effective in the production of
bicarbonate, which may be important for the temporary storage of
lactic acid produced during intense training. GLUTAVOL, unique in the
market, adds N Acetyl L Glutamine which is the acetylated form of L-glutamine,
NAG is more stable in water and metabolically more efficient at
delivering Glutamine to skeletal muscle than conventional Glutamine
or Glutamine Peptide supplements. Studies support that with the extra
intake of N Acetyl L Glutamine you can improve up to 400% in increases in
levels of Growth Hormone. In this way, we always ensure muscle gains
and we say goodbye to muscle catabolism.

GLUTAVOL is the new Matrix L-Gluamine made from BEVERLY NUTRITION. It is the new mix of L-Glutamine and N-Acetyl L-Glutamine. Recover your muscles after training fast and furious. The best and fast recover product for serious bodybuilders. Let your muscles growth and recover after your workout.

Bottle with 250 gr. Delicious Blue Raspberry flavor.

Use: Take 1 scoop in a glass of water after training.

 

DATASHEETGLUTAVOL 250 GRS

LEGAL NOTE: Products reviewed here are food supplements or as established by European Directive 2002/46/EC on food supplements and all can be legally sold in all countries of the European Community, under Articles 28, 29 and 30 of the treaty the European Community and by Articles 1 to 4 of the European Parliament Decision 3052/95/EC number. Dietary supplements are not trying to replace a balanced and varied diet, are presented only in order to supplement the intake of nutrients of a normal diet. Neither treat, prevent, diagnose or cure any disease, acts attributable to drugs, as defined by European Directive 2004/27/EC of 31 March, the Council and European Parliament on medicinal products.